| dc.contributor.author | Buga, Diana | |
| dc.contributor.author | Hotineanu, Adrian | |
| dc.contributor.author | Taran, Natalia | |
| dc.contributor.author | Ivancov, Grigorii | |
| dc.contributor.author | Pîrvu, Victor | |
| dc.contributor.author | Peltec, Angela | |
| dc.date.accessioned | 2020-11-11T15:02:24Z | |
| dc.date.available | 2020-11-11T15:02:24Z | |
| dc.date.issued | 2020-10 | |
| dc.identifier.uri | https://stiinta.usmf.md/ro/manifestari-stiintifice/zilele-universitatii | |
| dc.identifier.uri | https://repository.usmf.md/handle/20.500.12710/12902 | |
| dc.description | Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu”, Catedra de chirurgie nr. 2, Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu”, Laboratorul de gastroenterologie, Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu”, Disciplina de gastroenterologie, Congresul consacrat aniversării a 75-a de la fondarea Universității de Stat de Medicină și Farmacie „Nicolae Testemițanu” din Republica Moldova, Ziua internațională a științei pentru pace și dezvoltare | en_US |
| dc.description.abstract | Introduction: Evolution of liver cirrhosis induced by Delta virus is more severe in comparison with monoinfection HBV being grevated by numerous complications. Purpose The aim of this study was to compare clinical evolution of patients with liver cirrhosis induced by Delta and B viral infection that are on the waiting list for liver transplantation in Republic of Moldova. Material and methods : In side of the national transplant program was performed a retrospective study on two groups of patients with liver cirrhosis that are on the waiting list for liver transplant since February 2013 to January 2020. In each group were included 40 patients (1st group – the patients diagnosed with liver cirrhosis of HBV/HDV etiology, 2nd group – the patients diagnosed with liver cirrhosis of HBV etiology.Conclusions. Although VHD infection is not an independent mortality predictive factor, it imparts a more aggressive course of evolution. Patients with liver cirrhosis HBV/HDV during the follow-up period had significantly less survival compared to patients with HBV liver cirrhosis (p=0.014). | en_US |
| dc.language.iso | en | en_US |
| dc.publisher | Universitatea de Stat de Medicină şi Farmacie "Nicolae Testemiţanu" din Republica Moldova | en_US |
| dc.title | Survival of the patients with HDV liver cirrhosis from the waiting list for liver transplantation | en_US |
| dc.type | Other | en_US |